Correction to: Castration-resistant prostate cancer patients who had poor response on first androgen deprivation therapy would obtain certain clinical benefit from early docetaxel administration.

Correction to: Castration-resistant prostate cancer patients who had poor response on first androgen deprivation therapy would obtain certain clinical benefit from early docetaxel administration.
Int J Clin Oncol. 2019 Mar 02;:
Authors: Shigeta K, Kosaka T, Hongo H, Yanai Y, Matsumoto K, Morita S, Mizuno R, Shinojima T, Kikuchi E, Oya M
Abstract
The original article can be found online.
PMID: 30826960 [PubMed - as supplied by publisher]

Source: Clinical Prostate Cancer - March 1, 2019 Category: Cancer & Oncology Authors: Shigeta K, Kosaka T, Hongo H, Yanai Y, Matsumoto K, Morita S, Mizuno R, Shinojima T, Kikuchi E, Oya M Tags: Int J Clin Oncol Source Type: research